You can buy or sell ALPN and other stocks, options, ETFs, and crypto commission-free!
Alpine Immune Sciences, Inc. Common Stock, also called Alpine Immune Sciences, is a development-stage pharmaceutical company, which engages in the discovering of protein-based immunotherapies therapies targeting the immune synapse to treat cancer, autoimmune, and inflammatory disorders. Read More It offers Immunotherapy, Immune Synapse, vIgD Platform Technology, and TIP Program. The company was founded in 2015 and is headquartered in Seattle, WA.
52 Week High
52 Week Low
Earnings Preview: Alpine Immune Sciences (ALPN) Q1 Earnings Expected to Decline
The market expects Alpine Immune Sciences (ALPN) to deliver a year-over-year decline in earnings on lower revenues when i t report s results for the quarter ended March 2019. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.
Simply Wall StApr 24
Need To Know: Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Insiders Have Been Buying Shares
We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we’d be remiss not to mention that insider sales have been known to precede tough periods for a business. So before you buy or sell Alpine Immune Sciences, Inc. (NASDAQ:ALPN), you may well want to know whether insiders have been buying or selling. What Is Insider Selling? It is perfectly legal for company insiders, including board members, to buy and sell stock in a company. However, rules govern i...
Yahoo FinanceApr 24
Have Insiders Been Buying Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Shares?
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are also plenty of examples of share prices declining precipitously after insiders have sold shares. So shareholders might well want to know whether insiders have been buying or selling shares in Alpine Immune Sciences, Inc. (NASDAQ:ALPN). What Is Insider Selling? Scroll to continue with content Ad It is perfectly legal for company insiders, including board members, to buy and sell stock in a co...
-$0.69 per share
-$0.70 per share